Silo Pharma, Inc.
SILO • NASDAQ
Silo Pharma, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Eric Weisblum, with a market cap of $10.1M.
Market Cap$10.1M
Employees3.0
CEOEric Weisblum
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 8, 2026 · In 2 weeksAfter Market Close · Q1 2026
Financials
SIL
Silo Pharma, Inc. FAQ
Common questions about Silo Pharma, Inc.
Silo Pharma, Inc. is scheduled to report earnings for Q1 2026 on May 8, 2026 after market close. Analysts estimate revenue of $18.0K.
Silo Pharma, Inc. has approximately 3 employees.